SARS-CoV-2 Spike RBD (receptor binding domain), 513-520-Lys(Biotin-LC)

This peptide sequence represents residues 513-520 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.

Online Inquiry

CAT#S29020
SequenceOne Letter Code: LSFELLHA-K(Biotin-LC)-NH2
Three-Letter Code: H-Leu-Ser-Phe-Glu-Leu-Leu-His-Ala-Lys(Biotin-LC)-NH2
Purity95%
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

  ProTx II, a 30-amino acid, disulfide-rich peptide toxin, isolated from the venom of the tarantula, Thrixopelma ...

 Tertiapin-Q (TPN-Q) is a small compact protein that contains twenty-one amino acids, which derived from bee veno ...

of Tripeptide-1  The tripeptide-1 (glycyl-L-histadyl-L-lysine or GHK) is primarily known as carrier peptides. It ...

 Iron chelating agent is a new type of iron-removing treatment based on the combination of directional and in viv ...

 Norleual is a potent inhibitor of the HGF/Met system, which inhibited the prosurvival effects of HGF and suppres ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.